LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | GW843682X | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1517 | 4056 | 0.3744 | 0.1272 |
MCF7 | GW843682X | 1.11 | uM | LJP6 | 72 | hr | 1235 | 1433 | 4056 | 0.3534 | 0.0904 |
MCF7 | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1328 | 4056 | 0.3277 | 0.0433 |
MCF7 | GW843682X | 10 | uM | LJP6 | 72 | hr | 1235 | 1612 | 4056 | 0.3976 | 0.1682 |
MCF7 | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3513 | 4267 | 0.8246 | 0.7956 |
MCF7 | HG-5-113-01 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 2603 | 4267 | 0.6116 | 0.5180 |
MCF7 | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1706 | 4267 | 0.4006 | 0.1983 |
MCF7 | HG-5-113-01 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1446 | 4267 | 0.3389 | 0.0915 |
MCF7 | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1371 | 4267 | 0.3216 | 0.0600 |
MCF7 | HG-5-113-01 | 10 | uM | LJP5 | 72 | hr | 1235 | 883 | 4267 | 0.2073 | -0.1712 |
MCF7 | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 2625 | 4056 | 0.6466 | 0.5496 |
MCF7 | HG-5-88-01 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 2639 | 4056 | 0.6514 | 0.5573 |
MCF7 | HG-5-88-01 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 2225 | 4056 | 0.5484 | 0.4088 |
MCF7 | HG-5-88-01 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 1895 | 4056 | 0.4673 | 0.2834 |
MCF7 | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1501 | 4056 | 0.3699 | 0.1198 |
MCF7 | HG-5-88-01 | 10 | uM | LJP6 | 72 | hr | 1235 | 1192 | 4056 | 0.2939 | -0.0207 |
MCF7 | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4834 | 4056 | 1.1918 | 1.2152 |
MCF7 | HG-6-64-01 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 4613 | 4056 | 1.1372 | 1.1557 |
MCF7 | HG-6-64-01 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3989 | 4056 | 0.9847 | 0.9816 |
MCF7 | HG-6-64-01 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 3432 | 4056 | 0.8470 | 0.8153 |
MCF7 | HG-6-64-01 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 2586 | 4056 | 0.6377 | 0.5385 |
MCF7 | HG-6-64-01 | 10 | uM | LJP6 | 72 | hr | 1235 | 701 | 4056 | 0.1733 | -0.2817 |
MCF7 | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3207 | 4267 | 0.7514 | 0.7040 |
MCF7 | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 2830 | 4267 | 0.6631 | 0.5890 |
MCF7 | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 2689 | 4267 | 0.6306 | 0.5451 |